LLY ▲ +0.0% - Eli Lilly and Company
$LLY *LILLY'S RETATRUTIDE CUTS WEIGHT AVG 20.8% OVER 80 WKS IN PH. 3 *ELI LILLY - TO SUBMIT BIOLOGICS LICENSE APPLICATION FOR RETATRUTIDE IN Q1 2027
29-SEP-2026 06:12 PM ET
Share this post
More filings for $LLY
LLY ▼ -0.2% - Eli Lilly and CompanySep 29, 2026LLY ▼ -0.8% - Eli Lilly and CompanySep 29, 2026LLY ▼ -0.1% - Eli Lilly and CompanySep 29, 2026LLY ▲ +0.2% - Eli Lilly and CompanySep 29, 2026LLY ▲ +0.3% - Eli Lilly and CompanySep 29, 2026LLY ▲ +0.6% - Eli Lilly and CompanySep 28, 2026
View full $LLY filing history →💬 Comments
Loading comments…
Leave a comment